ArticlePsychopharmacology2026
A naturalistic examination of the effects of chronic and acute cannabis use on cognition and perceived symptoms of attention-deficit/hyperactivity disorder.
Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
rationalePeople with attention-deficit/hyperactivity disorder (ADHD) are more likely to use cannabis. However, the effects of chronic and acute cannabis use on people with ADHD remain unclear.
methods104 adults (26 cannabis users with ADHD, 26 non-users with ADHD, 26 cannabis users without ADHD, and 26 non-users without ADHD) were recruited to assess the impacts of cannabis use on perceived ADHD symptoms and cognition, through a repeated-measures, quasi-experimental study. In session one, participants completed a battery of cognitive tests and provided ADHD symptom (impulsivity, hyperactivity, inattention) and affect (irritability, anxiety, mood) ratings. In session two, cannabis users were observed using their own cannabis product while non-users remained sober, prior to completing the same battery of cognitive tests and symptom ratings.
resultsChronic cannabis users with ADHD self-reported less severe sluggish cognitive tempo than non-users with ADHD. Nevertheless, chronic cannabis users with (and without) ADHD demonstrated worse performance on two objective tests of cognition. Intoxicated cannabis users with ADHD self-reported reductions in impulsivity, irritability, and anxiety as well as enhanced mood, and demonstrated reductions in impulsive responding on two cognitive tests. Nevertheless, intoxicated cannabis users with (and without) ADHD demonstrated reductions in performance on five of the other cognitive outcomes.
conclusionThe present study provides limited evidence that acute cannabis intoxication may selectively reduce subjective and objective impulsivity in people with ADHD, while impairing several other aspects of cognition. In contrast, chronic cannabis use appears to reduce perceptions of sluggish cognitive tempo without producing any objective benefits to cognition.
Indexed as
Identifiers
41062851What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.